Patents
July 23, 2021
Amgen Denied Petition to Rehear Enablement Requirements for Biotech Patents By: Katie Rubino On June 21, 2021 the Court of Appeals for the Federal Circuit […]
May 7, 2021
American Chemical Society Selects Katie Rubino to Present on Developments in Cannabis IP Rights Katie Rubino spoke on intellectual property and business strategies in the […]
March 21, 2021
Inc. Magazine Applauds Caldwell IP’s “Win-Win Business Model” in the March/April Issue Caldwell IP is spotlighted in the March/April 2021 print issue of […]
March 3, 2021
American Chemical Health & Safety Journal Publishes “Developments and Trends in Cannabis Intellectual Property Rights” by Katie Rubino American Chemical Health & Safety Journal […]
February 24, 2021
Artificial Intelligence and Patents: Inventing Inventors By: Brice Turner Who are the inventors of patents? Since George Washington signed the first patent in 1790, […]
February 17, 2021
A review of Issued Patents Filed under the USPTO’s COVID Prioritized Program By: Katie Rubino COVID-19 Prioritized Examination Program In May 2020, […]
July 23, 2020
When Patents and Trademarks Coincide By: Julie Tolek and Ed Mantilla Inevitably, whether it be while launching a startup, working on a product, or during […]
May 21, 2020
USPTO LAUNCHES PRIORITIZED PROGRAM FOR COVID-19 RELATED INVENTIONS By: Katie Rubino On May 8, 2020, the United States Patent and Trademark Office (USPTO) announced the new […]
April 16, 2020
COVID-19: HYDROXYCHLOROQUINE- FRIEND OR FOE? By: Katie Rubino Around the world, there are presently 1,696,588 confirmed cases of COVID-19 in 213 countries and territories.[i] Further, some […]
March 26, 2020
CORONAVIRUS CATASTROPHE: THE VALUE OF INTELLECTUAL PROPERTY DURING AN ECONOMIC DOWNTURN By: Katie Rubino As the number of cases of the novel coronavirus around the world […]